The Cigna Group (CI) is down 3.2% today. Here is some analysis on what might have caused this price movement.
Analysis: The most likely driver was a muted investor-day reaction. Management introduced a new long-term strategy and a multiyear productivity program, but it only reaffirmed 2026 guidance rather than raising it, which may have disappointed investors looking for a stronger near-term earnings catalyst.
Details:
Sources:
The Cigna Group, SEC, StreetInsider
Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.
$CI Insider Trading Activity
$CI insiders have traded $CI stock on the open market 17 times in the past 6 months. Of those trades, 0 have been purchases and 17 have been sales.
Here’s a breakdown of recent trading of $CI stock by insiders over the last 6 months:
- DAVID CORDANI (Chairman & CEO) has made 0 purchases and 13 sales selling 201,878 shares for an estimated $59,114,186.
- NICOLE S JONES (See Remarks) has made 0 purchases and 2 sales selling 22,113 shares for an estimated $6,118,099.
- JAMIE G KATES (Chief Accounting Officer) sold 899 shares for an estimated $268,452
- EVERETT NEVILLE (See Remarks) sold 617 shares for an estimated $175,258
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
$CI Hedge Fund Activity
We have seen 798 institutional investors add shares of $CI stock to their portfolio, and 657 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- JPMORGAN CHASE & CO added 5,194,363 shares (+inf%) to their portfolio in Q2 2026, for an estimated $1,431,981,991
- FMR LLC removed 2,939,083 shares (-26.8%) from their portfolio in Q2 2026, for an estimated $810,246,401
- SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. added 2,178,861 shares (+inf%) to their portfolio in Q2 2026, for an estimated $600,668,400
- HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC added 1,527,047 shares (+307.2%) to their portfolio in Q2 2026, for an estimated $420,976,316
- PRICE T ROWE ASSOCIATES INC /MD/ removed 1,307,781 shares (-50.8%) from their portfolio in Q2 2026, for an estimated $360,529,066
- NATIONAL BANK OF CANADA /FI/ added 1,240,125 shares (+631.7%) to their portfolio in Q2 2026, for an estimated $341,877,660
- TWO SIGMA INVESTMENTS, LP added 1,171,762 shares (+182.7%) to their portfolio in Q2 2026, for an estimated $323,031,348
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
$CI Government Contracts
We have seen $3,232,020 of award payments to $CI over the last year.
Here are some of the awards which we have have seen pay out the most over the last year:
- MEDICAL, DENTAL, AND VISION INSURANCE FOR THE MNG STUDENTS AND DEPENDENTS IN CONUS SCHOOLS/TRAINING.: $3,217,401
- VEHICLE INSURANCE: $14,619
To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard. You can access data on government contracts through the Quiver Quantitative API government contracts endpoint.
$CI Price Targets
Multiple analysts have issued price targets for $CI recently. We have seen 11 analysts offer price targets for $CI in the last 6 months, with a median target of $338.0.
Here are some recent targets:
- Lance Wilkes from Bernstein set a target price of $381.0 on 07/09/2026
- Ann Hynes from Mizuho set a target price of $340.0 on 06/08/2026
- Andrew Mok from Barclays set a target price of $304.0 on 05/26/2026
- A.J. Rice from UBS set a target price of $400.0 on 05/22/2026
- Erin Wright from Morgan Stanley set a target price of $361.0 on 05/20/2026
- George Hill from Deutsche Bank set a target price of $302.0 on 05/20/2026
- Jason Cassorla from Guggenheim set a target price of $338.0 on 05/04/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.